Ryan H. Saadi
Chief Executive Officer at Tevogen Inc.
Sits on 1 board. Last updated September 28, 2026
Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 3 years
- Director since
- 2024
3 years of board service in total across 1 board, counting each seat separately. Longest: Tevogen Inc., 2 years.
Tevogen Inc.
Director · Chief Executive Officer
Chief executive roles
Tevogen Inc.
· Chief Executive Officer
Since February 2024
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jul 10, 2026 | Tevogen Inc. | Grant or award | +1,220,000 | — | — |
| Dec 18, 2025 | Tevogen Inc. | Gift | −50,000 | — | — |
| Dec 11, 2025 | Tevogen Inc. | Gift | −460,000 | — | — |
| Aug 15, 2025 | Tevogen Inc. | Gift | −20,000 | — | — |
| Jun 27, 2025 | Tevogen Inc. | Grant or award | +8,000,000 | — | — |
| Jun 9, 2025 | Tevogen Inc. | Open-market sale | −1,438,206 | $1.23 | $1,768,993 |
| Jun 5, 2024 | Tevogen Inc. | Open-market purchase | +2,607 | $0.77 | $2,008 |
| Feb 14, 2024 | Tevogen Inc. | Grant or award | +98,901,098 | — | — |
| Feb 14, 2024 | Tevogen Inc. | Grant or award | +19,348,954 | — | — |
| Feb 14, 2024 | Tevogen Inc. | Grant or award | +193,923 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.